However, a few studies indicate that YKL-40 concentration is slightly increased in the plasma of AD patients (Olsson et al., 2016); the overlap between AD patients and cognitively normal controls was, however, too large for the marker to be used clinically. The gene discussed is CHI3L1; the disease is Alzheimer disease.